In rats with myocardial infarction, SGLT2i attenuate myocardial fibrosis by activating the signal transducer and activator of transcription 3 (STAT3) pathway and reducing the release of superoxide and nitrotyrosine [127]. The gene discussed is STAT3; the disease is myocardial infarction.